{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:23:08Z","timestamp":1780471388653,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permanent damage and worse outcomes. This study explored caregiver perspectives on barriers they encountered while navigating diagnosis and care for their child\u2019s scleroderma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, caregivers of juvenile LS or SSc patients were recruited from a virtual family scleroderma educational conference and a juvenile scleroderma online interest group. The survey queried respondents about their child\u2019s condition and factors affecting diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The response rate was 61% (73\/120), with 38 parents of LS patients and 31 parents of SSc patients. Most patients were female (80%) and over half were non-Hispanic white (55%). Most families had at least one person with a college education or higher (87%), traveled\u2009\u2264\u20092\u00a0h to see their rheumatologist (83%), and had private insurance (75%). Almost half had an annual household income\u2009\u2265\u2009$100,000 (46%). Families identified the following factors as barriers to care: lack of knowledge about scleroderma in the medical community, finding reliable information about pediatric scleroderma, long wait times\/distances for a rheumatology\/specialist appointment, balance of school\/work and child\u2019s healthcare needs, medication side effects, and identifying effective medications. The barrier most identified as a major problem was the lack of knowledge about juvenile scleroderma in the medical community. Public insurance, household income less than $100,000, and Hispanic ethnicity were associated with specific barriers to care. Lower socioeconomic status was associated with longer travel times to see the rheumatologist\/specialist. Diagnosis and systemic treatment initiation occurred at greater than one year from initial presentation for approximately 28% and 36% of patients, respectively. Families of LS patients were commonly given erroneous information about the disease, including on the need and importance of treating active disease with systemic immunosuppressants in patients with deep tissue or rapidly progressive disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Caregivers of children with LS or SSc reported numerous common barriers to the diagnosis, treatment, and ongoing care of juvenile scleroderma. The major problem highlighted was the lack of knowledge of scleroderma within the general medical community. Given that most of the caregiver respondents to the survey had relatively high socioeconomic status, additional studies are needed to reach a broader audience, including caregivers with limited English proficiency, geographical limitations, and financial constraints, to determine if the identified problems are generalizable. Identifying key care barriers will help direct efforts to address needs, reduce disparities in care, and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-023-00819-6","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:04:17Z","timestamp":1682427857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers\u2019 perspectives"],"prefix":"10.1186","volume":"21","author":[{"given":"Leigh A.","family":"Stubbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Guffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Loccke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin Moriarty","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Ardalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Ganske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Sivaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vasquez-Canizares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raegan D.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata S.","family":"Maricevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn S.","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-2866","authenticated-orcid":false,"given":"Suzanne C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Childhood Arthritis, Rheumatology Research Alliance (CARRA) Scleroderma Workgroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"3","key":"819_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/bjd.18512","volume":"182","author":"CK Zigler","year":"2020","unstructured":"Zigler CK, Ardalan K, Lane S, Schollaert KL, Torok KS. A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity. Br J Dermatol. 2020;182(3):625\u201335.","journal-title":"Br J Dermatol"},{"issue":"2","key":"819_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/acr2.1019","volume":"1","author":"EY Wu","year":"2019","unstructured":"Wu EY, Li SC, Torok KS, Virkud YV, Fuhlbrigge RC, Rabinovich CE, et al. Baseline description of the juvenile localized scleroderma subgroup from the childhood arthritis and rheumatology research alliance legacy registry. ACR Open Rheumatol. 2019;1(2):119\u201324.","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"819_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.pcl.2012.03.011","volume":"59","author":"KS Torok","year":"2012","unstructured":"Torok KS. Pediatric scleroderma: systemic or localized forms. Pediatr Clin North Am. 2012;59(2):381\u2013405.","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"819_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.autrev.2018.02.004","volume":"17","author":"G Martini","year":"2018","unstructured":"Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review. Autoimmun Rev. 2018;17(7):727\u201334.","journal-title":"Autoimmun Rev"},{"issue":"245\u201356","key":"819_CR5","first-page":"e2","volume":"234","author":"SC Li","year":"2021","unstructured":"Li SC, O\u2019Neil KM, Higgins GC. Morbidity and disability in juvenile localized scleroderma: the case for early recognition and systemic immunosuppressive treatment. J Pediatr. 2021;234(245\u201356):e2.","journal-title":"J Pediatr"},{"issue":"12","key":"819_CR6","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/acr.23547","volume":"70","author":"BE Stevens","year":"2018","unstructured":"Stevens BE, Torok KS, Li SC, Hershey N, Curran M, Higgins GC, et al. Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis: results from the childhood arthritis and rheumatology research alliance legacy registry. Arthritis Care Res (Hoboken). 2018;70(12):1806\u201313.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"819_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","volume":"65","author":"SC Li","year":"2018","unstructured":"Li SC. Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin North Am. 2018;65(4):757\u201381.","journal-title":"Pediatr Clin North Am"},{"key":"819_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/acr.20070","volume":"62","author":"A Herrick","year":"2010","unstructured":"Herrick A, Ennis H, Bhushan M, Silman A, Baildam E. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res. 2010;62:213\u20138.","journal-title":"Arthritis Care Res"},{"issue":"11","key":"819_CR9","first-page":"2143","volume":"21","author":"PM Pelkonen","year":"1994","unstructured":"Pelkonen PM, Jalanko HJ, Lantto RK, M\u00e4kel\u00e4 AL, Pietik\u00e4inen MA, Savolainen HA, et al. Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland. J Rheumatol. 1994;21(11):2143\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"819_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/BOR.0b013e328323daad","volume":"21","author":"KL Demas","year":"2009","unstructured":"Demas KL, Costenbader KH. Disparities in lupus care and outcomes. Curr Opin Rheumatol. 2009;21(2):102\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"819_CR11","doi-asserted-by":"publisher","first-page":"1759720x2211371","DOI":"10.1177\/1759720X221137127","volume":"14","author":"EI Ciofoaia","year":"2022","unstructured":"Ciofoaia EI, Pillarisetty A, Constantinescu F. Health disparities in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2022;14:1759720x221137127.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"819_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.rdc.2021.09.014","volume":"48","author":"AM Akinsete","year":"2022","unstructured":"Akinsete AM, Woo JMP, Rubinstein TB. Disparities in pediatric rheumatic diseases. Rheum Dis Clin North Am. 2022;48(1):183\u201398.","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"819_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/acr.24991","volume":"75","author":"WD Soulsby","year":"2023","unstructured":"Soulsby WD, Lawson E, Pantell MS. Cumulative social disadvantage associated with childhood arthritis: a cross-sectional analysis of the national survey of children\u2019s health. Arthritis Care Res (Hoboken). 2023;75(1):3\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"819_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12969-021-00610-5","volume":"19","author":"N Balmuri","year":"2021","unstructured":"Balmuri N, Soulsby WD, Cooley V, Gerber L, Lawson E, Goodman S, et al. Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis. Pediatr Rheumatol Online J. 2021;19(1):122.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"819_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/acr2.11246","volume":"3","author":"J Neely","year":"2021","unstructured":"Neely J, Shalen J, Sturrock H, Kim S, Childhood A, Rheumatology Research Alliance I. Access to care and diagnostic delays in juvenile dermatomyositis: results from the childhood arthritis and rheumatology research alliance legacy registry. ACR Open Rheumatol. 2021;3(5):349\u201354.","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"819_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/acr.23285","volume":"70","author":"TB Rubinstein","year":"2018","unstructured":"Rubinstein TB, Mowrey WB, Ilowite NT, Wahezi DM, Childhood A, Rheumatology Research Alliance I. Delays to care in pediatric lupus patients: data from the childhood arthritis and rheumatology research alliance legacy registry. Arthritis Care Res (Hoboken). 2018;70(3):420\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"819_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/rheumatology\/ker521","volume":"51","author":"DP Hawley","year":"2012","unstructured":"Hawley DP, Baildam EM, Amin TS, Cruikshank MK, Davidson JE, Dixon J, et al. Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK. Rheumatology (Oxford). 2012;51(7):1235\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"819_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/713612410","volume":"10","author":"TG Heckman","year":"1998","unstructured":"Heckman TG, Somlai AM, Peters J, Walker J, Otto-Salaj L, Galdabini CA, et al. Barriers to care among persons living with HIV\/AIDS in urban and rural areas. AIDS Care. 1998;10(3):365\u201375.","journal-title":"AIDS Care"},{"issue":"1","key":"819_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-017-0184-y","volume":"15","author":"DR Bullock","year":"2017","unstructured":"Bullock DR, Vehe RK, Zhang L, Correll CK. Telemedicine and other care models in pediatric rheumatology: an exploratory study of parents\u2019 perceptions of barriers to care and care preferences. Pediatr Rheumatol Online J. 2017;15(1):55.","journal-title":"Pediatr Rheumatol Online J"},{"key":"819_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12969-015-0028-6","volume":"13","author":"CK Correll","year":"2015","unstructured":"Correll CK, Spector LG, Zhang L, Binstadt BA, Vehe RK. Barriers and alternatives to pediatric rheumatology referrals: survey of general pediatricians in the United States. Pediatr Rheumatol Online J. 2015;13:32.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"819_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/acr.23285","volume":"70","author":"TB Rubinstein","year":"2018","unstructured":"Rubinstein TB, Mowrey WB, Ilowite NT, Wahezi DM. Delays to care in pediatric lupus patients: data from the childhood arthritis and rheumatology research alliance legacy registry. Arthritis Care Res (Hoboken). 2018;70(3):420\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"819_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/acr.24497","volume":"74","author":"C Correll","year":"2022","unstructured":"Correll C, Ditmyer M, Mehta J, Imundo L, Klein-Gitelman M, Monrad S, et al. 2015 American college of rheumatology workforce studyand demand projections of pediatric rheumatologyworkforce, 2015\u20132030. Arthritis Care Res (Hoboken). 2022;74:340\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"819_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jaad.2014.11.019","volume":"72","author":"N Strickland","year":"2015","unstructured":"Strickland N, Patel G, Strickland A, Jacobe H. Attitudes and trends in the treatment of morphea: a national survey. J Am Acad Dermatol. 2015;72(4):727\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"819_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pde.13281","volume":"35","author":"MM Tollefson","year":"2018","unstructured":"Tollefson MM, Chiu YE, Brandling-Bennett HA, Pope E. Discordance of pediatric morphea treatment by pediatric dermatologists. Pediatr Dermatol. 2018;35(1):47\u201354.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"819_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3899\/jrheum.090708","volume":"37","author":"SC Li","year":"2010","unstructured":"Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O\u2019Neil KM. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol. 2010;37(1):175\u201381.","journal-title":"J Rheumatol"},{"issue":"8","key":"819_CR26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","volume":"64","author":"SC Li","year":"2012","unstructured":"Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, et al. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2012;64(8):1175\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"819_CR27","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","volume":"78","author":"F Zulian","year":"2019","unstructured":"Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM, et al. Consensus-based recommendations for the management of juvenile localised scleroderma. Ann Rheum Dis. 2019;78(8):1019\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"819_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.rdc.2021.07.014","volume":"47","author":"N Vasquez-Canizares","year":"2021","unstructured":"Vasquez-Canizares N, Li SC. Juvenile Localized Scleroderma: Updates and Differences from Adult-Onset Disease. Rheum Dis Clin North Am. 2021;47(4):737\u201355.","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"819_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/BOR.0000000000000886","volume":"34","author":"SC Li","year":"2022","unstructured":"Li SC. Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments. Curr Opin Rheumatol. 2022;34(5):245\u201354.","journal-title":"Curr Opin Rheumatol"},{"key":"819_CR30","first-page":"343","volume":"20","author":"H Kornreich","year":"1977","unstructured":"Kornreich H, King K, Bernstein B, Singsen B, Hanson V. Scleroderma in childhood. Arthritis Rheum. 1977;20:343\u201350.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"819_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-4362.1996.tb03633.x","volume":"35","author":"LE Eubanks","year":"1996","unstructured":"Eubanks LE, McBurney EI, Galen W, Reed R. Linear scleroderma in children. Int J Dermatol. 1996;35(5):330\u20136.","journal-title":"Int J Dermatol"},{"key":"819_CR32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/01241398-200007000-00005","volume":"20","author":"C Bottoni","year":"2000","unstructured":"Bottoni C, Reinker K, Gardner R, Person D. Scleroderma in childhood: a 35-year history of cases and review of the literature. J Pediatr Orthop. 2000;20:442\u20139.","journal-title":"J Pediatr Orthop"},{"key":"819_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/rheumatology\/35.4.364","volume":"35","author":"F van den Hoogen","year":"1996","unstructured":"van den Hoogen F, Boerbooms A, Swaak A, Rasker J, van Lier H, van de Putte L. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, fol- lowed by a 24 week observational trial. Br J Rheumatol. 1996;35:364\u201372.","journal-title":"Br J Rheumatol"},{"issue":"7","key":"819_CR34","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","volume":"63","author":"F Zulian","year":"2011","unstructured":"Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2011;63(7):1998\u20132006.","journal-title":"Arthritis Rheum"},{"key":"819_CR35","first-page":"CD005027","volume":"7","author":"JV Albuquerque","year":"2019","unstructured":"Albuquerque JV, Andriolo BN, Vasconcellos MR, Civile VT, Lyddiatt A, Trevisani VF. Interventions for morphea. Cochrane Database Syst Rev. 2019;7:CD005027.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"819_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-020-01439-z","volume":"15","author":"S Sanges","year":"2020","unstructured":"Sanges S, Farhat MM, Assaraf M, Galland J, Rivi\u00e8re E, Roubille C, et al. Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis. Orphanet J Rare Dis. 2020;15(1):159.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"819_CR37","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3899\/jrheum.190311","volume":"47","author":"SC Li","year":"2020","unstructured":"Li SC, Torok KS, Rabinovich CE, Dedeoglu F, Becker ML, Ferguson PJ, et al. Initial results from a pilot comparative effectiveness study of 3 methotrexate-based consensus treatment plans for juvenile localized scleroderma. J Rheumatol. 2020;47(8):1242\u201352.","journal-title":"J Rheumatol"},{"issue":"12","key":"819_CR38","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1093\/rheumatology\/keab238","volume":"60","author":"SC Li","year":"2021","unstructured":"Li SC, Higgins GC, Chen M, Torok KS, Rabinovich CE, Stewart K, et al. Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma. Rheumatology (Oxford). 2021;60(12):5724\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"819_CR39","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/rheumatology\/keaa584","volume":"60","author":"I Foeldvari","year":"2021","unstructured":"Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, et al. Consensus-based recommendations for the management of juvenile systemic sclerosis. Rheumatology (Oxford). 2021;60(4):1651\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"819_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.rdc.2021.07.004","volume":"47","author":"KS Torok","year":"2021","unstructured":"Torok KS. Updates in systemic sclerosis treatment and applicability to pediatric scleroderma. Rheum Dis Clin North Am. 2021;47(4):757\u201380.","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00819-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T07:34:04Z","timestamp":1702280044000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00819-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00819-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2440691\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"3 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Baylor College of Medicine Institution\u2019s Internal Review Board, protocol number H-50554. Consents were obtained for all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants consented to the publication of the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests, no relevant conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}